L & S Advisors’s Teladoc Health TDOC Stock Holding History

L & S Advisors’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-4,107	Closed	-$746K	–	387
2021 Q1	$746K	Sell	4,107 -8,256	-67%	-$1.91M	0.08%	227
2020 Q4	$2.47M	Buy	+12,363	New	+$2.51M	0.29%	122
2019 Q1	–	Sell	-12,405	Closed	-$615K	–	340
2018 Q4	$615K	Sell	12,405 -2,075	-14%	-$127K	0.12%	164
2018 Q3	$1.25M	Buy	+14,480	New	+$1.03M	0.16%	127

Other funds holding TDOC

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $189M AUM 10.96% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

L & S Advisors's TDOC Position: Q2 2021 in Review

L & S Advisors sold out of Teladoc Health (TDOC) in Q2 2021, closing a stake of 4,107 shares — an estimated $746K sold.

L & S Advisors first reported a position in TDOC in Q3 2018 and held it in 4 quarters. The position peaked at $2.47M in Q4 2020. 829 funds tracked by Wall St. Rank hold TDOC as of Q2 2021.

L & S Advisors reported no remaining Teladoc Health position as of Q2 2021 after selling out during the quarter.
L & S Advisors sold 4,107 Teladoc Health shares in Q2 2021, an estimated $746K.
L & S Advisors first reported a position in Teladoc Health in Q3 2018 and held it in 4 quarters.
L & S Advisors's Teladoc Health position peaked at $2.47M in Q4 2020.
829 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2021.

Based on L & S Advisors's 13F filing for Q2 2021, filed 12 Aug 2021.